About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
IP: Carlos Molina Cateriano Collaborators: Marta Aurora Rubiera del Fueyo, Lidia Garcia Guillamón, Manuel Requena Ruiz, Marta Olive Gadea, Maria Baladas Orti, Alvaro Garcia Tornel Garcia Camba, Ester Sanchez Gavilan, Olalla Pancorbo Rosal, Cristina Guirao Martinez, Claudia Meza Burgos, David Rodriguez Luna, Federica Rizzo, Renato Simonetti Funding agency: EUROPEAN COMMISSION Funding: 468090 Reference: HARMONICS_EIT-HEALTH-BP2022 Duration: 01/01/2022 - 31/12/2026
IP: Deborah Pareto Onghena Collaborators: Ingrid Galán Cartaña, Herena Eixarch Ahufinger, M Jesus Arevalo Navines, Caracterización de la DIScapacidad y la COgnición en sujetos con Esclerosis múltiple a partir de secuencias de Resonancia magné, Giorgio Colangelo Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI22/01709 Duration: 01/01/2023 - 30/06/2027
IP: Mª Ángeles Muchada López Collaborators: Carlos Molina Cateriano, Alvaro Garcia Tornel Garcia Camba, Nicoletta Brunelli Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI22/01928 Duration: 01/01/2023 - 30/06/2027
IP: Marta Aurora Rubiera del Fueyo Collaborators: Maria Teresa Rodriguez Acebes, Jerónimo Parra Parra, Pere Canals Canals, Pere Canals Canals, Maria Victoria Sala Sanz de Madrid, Maria Victoria Sala Sanz de Madrid, Ester Sanchez Gavilan, Ester Sanchez Gavilan, Claudia Meza Burgos, Claudia Meza Burgos, David Rodriguez Luna, Federica Rizzo Funding agency: EUROPEAN COMMISSION Funding: 567950 Reference: VALIDATE_MA.RUBIERA_HE_2021 Duration: 01/05/2022 - 30/04/2026
The funding will enable the company, emerged from the Vall d'Hebron ecosystem, to complete the clinical development of its technology and move closer to making it available to patients.
The RECUPERA project, led by DyCare and Ephion Health in collaboration with Vall d’Hebron, Eurecat, and the Ictus Foundation, will combine AI, computer vision, and biomechanical sensors to measure patient progress and tailor exercises to their needs.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
